Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001213900-25-088802·Climb Bio, Inc.
Schedule 13G ownership disclosure
Climb Bio, Inc.
Common Stock, par value $0.0001 per share · CUSIP: 28658R106
Event date: 2024-06-27
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Pontifax VI G.P. L.P.
Shares: 5,206,380.00 · Class: 7.7%
- Pontifax Management 4 G.P. (2015) Ltd.
Shares: 5,206,380.00 · Class: 7.7%
- Ran Nussbaum
Shares: 5,206,380.00 · Class: 7.7%
- Tomer Kariv
Shares: 5,206,380.00 · Class: 7.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-25-088802
- Form type
- SCHEDULE 13G
- Filer
- Climb Bio, Inc.
- CIK
- CIK 1768446
- Filed
- Sep 18, 2025
- Reporting period
- Jun 27, 2024
- Description
- Schedule 13G beneficial ownership